Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients
Nikolaus Jahn, Maral Saadati, Pierre Fenaux, et al.
Leukemia (2023) Vol. 37, Iss. 11, pp. 2187-2196
Open Access | Times Cited: 24

Showing 24 citing articles:

Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and Azacitidine
Hartmut Döhner, Keith W. Pratz, Courtney D. DiNardo, et al.
Blood (2024) Vol. 144, Iss. 21, pp. 2211-2222
Open Access | Times Cited: 24
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations
Hartmut Döhner, Courtney D. DiNardo, Frederick Appelbaum, et al.
Blood (2024) Vol. 144, Iss. 21, pp. 2169-2173
Closed Access | Times Cited: 22
Venetoclax Resistance in Acute Myeloid Leukemia
Sylvain Garciaz, Marie‐Anne Hospital, Yves Collette, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1091-1091
Open Access | Times Cited: 9
Impact of myelodysplasia‐related and additional gene mutations in intensively treated patients with NPM1‐mutated AML
Sibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response
Mingyue Yao, Wenzhong Yan, Wang Yf, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
Mithun Vinod Shah, Daniel A. Arber, Devendra Hiwase
American Journal of Hematology (2025)
Open Access | Times Cited: 1
Venetoclax efficacy on acute myeloid leukemia is enhanced by the combination with butyrate
Renshi Kawakatsu, Kenjiro Tadagaki, Kenta Yamasaki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Association between cigarette smoking, genetic polymorphism and myelodysplasia: A multicentric case-control study
N. Rodriguez, Marta Megido Lahera, José Ramón González Porras, et al.
Medicina Clínica (English Edition) (2025)
Closed Access
Prognostic impact of initial platelet count and post-induction platelet recovery in elderly AML patients: associated with circulating cytokines
Chun Ling, Na Cao, Xiaowei Niu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents
Tom Reuvekamp, Lok Lam Ngai, Daphne den Hartog, et al.
Leukemia (2025)
Open Access
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
Klaus Geißler, Zdeněk Kořı́stek, Teresa Bernal, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 5, pp. 1734-1745
Open Access | Times Cited: 4
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients
Adriane Halik, Marlon Tilgner, Patrı́cia Silva, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
The combination of venetoclax and quercetin exerts a cytotoxic effect on acute myeloid leukemia
Renshi Kawakatsu, Kenjiro Tadagaki, Kenta Yamasaki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
Marie Sébert, Lucie Freiman, Cendrine Chaffaut, et al.
Leukemia (2024) Vol. 38, Iss. 4, pp. 918-922
Closed Access | Times Cited: 2
Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with VEN-AZA for Newly Diagnosed Acute Myeloid Leukemia
Guillaume Berton, Bochra Sedaki, Erwann Collomb, et al.
Leukemia Research (2024) Vol. 141, pp. 107500-107500
Open Access | Times Cited: 2
Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype
Johanna Thomas, Usama‐Ur Rehman, Helena Bresser, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
Frank G. Rücker, Andrea Corbacioglu, Julia Krzykalla, et al.
HemaSphere (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 1
The combination of venetoclax and quercetin exerts a cytotoxic effect on acute myeloid leukemia
Renshi Kawakatsu, Kenjiro Tadagaki, Kenta Yamasaki, et al.
Research Square (Research Square) (2024)
Open Access
The prognostic significance of genetics in acute myeloid leukemia under venetoclax-based treatment
Shan Zheng, Yuxin Tong, Linlin Yang, et al.
Annals of Hematology (2024)
Closed Access
Acute Myeloid Leukemia with deletion 5q is an epigenetically distinct subgroup defined by heterozygous loss of KDM3B
Katherine A. Kelly, Linda Welte, Etienne Sollier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Consumo de cigarrillos, polimorfismos genéticos y mielodisplasia: un estudio de casos y controles
N. Rodriguez, Marta Megido Lahera, José Ramón González Porras, et al.
Medicina Clínica (2024)
Closed Access
Prognostic significance of angiogenesis-associated molecules and immunologic characteristic in elderly patients with acute myeloid leukemia
Can Chen, Yongfen Huang, Lingling Wang, et al.
Research Square (Research Square) (2024)
Open Access
Proteomics and NGS Analysis of Induced Myeloid Leukemia Cells
Uma Kumari, K. Sreenath Yadav
International Journal for Research in Applied Science and Engineering Technology (2023) Vol. 11, Iss. 9, pp. 105-112
Open Access
Unraveling germline predisposition in hematological neoplasms: Navigating complexity in the genomic era
Joaquín Jerez, Marta Santiago
Blood Reviews (2023) Vol. 64, pp. 101143-101143
Closed Access
Page 1

Scroll to top